Simulations Plus Inc
NASDAQ:SLP
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
27.22
50.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
SLP Price Targets Summary
Simulations Plus Inc
According to Wall Street analysts, the average 1-year price target for SLP is 58.14 USD with a low forecast of 47.47 USD and a high forecast of 68.25 USD.
SLP Last Price Targets
Simulations Plus Inc
The latest public price target was made on Jul 29, 2024 by Scott Schoenhaus from KeyBanc , who expects SLP stock to rise by 48% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Scott Schoenhaus
KeyBanc
|
47
USD
Upside 48% |
3 months ago
Jul 29, 2024
|
KeyBanc Starts Simulations Plus (SLP) at Overweight
StreetInsider
|
Matt Hewitt
Craig-Hallum
|
56
USD
Upside 76% |
5 months ago
Jun 13, 2024
|
Simulations Plus price target raised to $56 from $51 at Craig-Hallum
TheFly
|
Francois Brisebois
Oppenheimer
|
65
USD
Upside 104% |
5 months ago
Jun 13, 2024
|
Simulations Plus (SLP) PT Raised to $65 at Oppenheimer
StreetInsider
|
Francois Brisebois
Oppenheimer
|
67
USD
Upside 110% |
1 year ago
Jun 21, 2023
|
Simulations Plus Is High-Growth Investment Opportunity In The Wake Of Immunetrics Acquisition: Analyst
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SLP's stock price target?
Price Target
58.14
USD
According to Wall Street analysts, the average 1-year price target for SLP is 58.14 USD with a low forecast of 47.47 USD and a high forecast of 68.25 USD.
What is Simulations Plus Inc's Revenue forecast?
Projected CAGR
21%
For the last 8 years the compound annual growth rate for Simulations Plus Inc's revenue is 16%. The projected CAGR for the next 4 years is 21%.
What is Simulations Plus Inc's Operating Income forecast?
Projected CAGR
37%
For the last 8 years the compound annual growth rate for Simulations Plus Inc's operating income is 5%. The projected CAGR for the next 4 years is 37%.
What is Simulations Plus Inc's Net Income forecast?
Projected CAGR
28%
For the last 8 years the compound annual growth rate for Simulations Plus Inc's net income is 13%. The projected CAGR for the next 3 years is 28%.